These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11601929)

  • 1. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.
    Ramsey SD; Clarke L; Etzioni R; Higashi M; Berry K; Urban N
    Ann Intern Med; 2001 Oct; 135(8 Pt 1):577-88. PubMed ID: 11601929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summaries for patients. Cost-effectiveness of screening for microsatellite instability to detect hereditary nonpolyposis colorectal cancer.
    Ann Intern Med; 2001 Oct; 135(8 Pt 1):S-48. PubMed ID: 11680418
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
    Ladabaum U; Wang G; Terdiman J; Blanco A; Kuppermann M; Boland CR; Ford J; Elkin E; Phillips KA
    Ann Intern Med; 2011 Jul; 155(2):69-79. PubMed ID: 21768580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of a new strategy to identify HNPCC patients.
    Kievit W; de Bruin JH; Adang EM; Severens JL; Kleibeuker JH; Sijmons RH; Ruers TJ; Nagengast FM; Vasen HF; van Krieken JH; Ligtenberg MJ; Hoogerbrugge N
    Gut; 2005 Jan; 54(1):97-102. PubMed ID: 15591512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
    Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
    JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness.
    Reyes CM; Allen BA; Terdiman JP; Wilson LS
    Cancer; 2002 Nov; 95(9):1848-56. PubMed ID: 12404277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing.
    Christensen M; Katballe N; Wikman F; Primdahl H; Sørensen FB; Laurberg S; Ørntoft TF
    Cancer; 2002 Dec; 95(11):2422-30. PubMed ID: 12436451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary nonpolyposis colorectal cancer: preventive management.
    Annie Yu HJ; Lin KM; Ota DM; Lynch HT
    Cancer Treat Rev; 2003 Dec; 29(6):461-70. PubMed ID: 14585257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic testing for hereditary nonpolyposis colorectal cancer.
    Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
    Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based molecular detection of hereditary nonpolyposis colorectal cancer.
    Salovaara R; Loukola A; Kristo P; Kääriäinen H; Ahtola H; Eskelinen M; Härkönen N; Julkunen R; Kangas E; Ojala S; Tulikoura J; Valkamo E; Järvinen H; Mecklin JP; Aaltonen LA; de la Chapelle A
    J Clin Oncol; 2000 Jun; 18(11):2193-200. PubMed ID: 10829038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.
    Syngal S; Weeks JC; Schrag D; Garber JE; Kuntz KM
    Ann Intern Med; 1998 Nov; 129(10):787-96. PubMed ID: 9841584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.
    de Leon MP; Pedroni M; Benatti P; Percesepe A; Di Gregorio C; Foroni M; Rossi G; Genuardi M; Neri G; Leonardi F; Viel A; Capozzi E; Boiocchi M; Roncucci L
    Gut; 1999 Jul; 45(1):32-8. PubMed ID: 10369701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
    Umar A; Boland CR; Terdiman JP; Syngal S; de la Chapelle A; Rüschoff J; Fishel R; Lindor NM; Burgart LJ; Hamelin R; Hamilton SR; Hiatt RA; Jass J; Lindblom A; Lynch HT; Peltomaki P; Ramsey SD; Rodriguez-Bigas MA; Vasen HF; Hawk ET; Barrett JC; Freedman AN; Srivastava S
    J Natl Cancer Inst; 2004 Feb; 96(4):261-8. PubMed ID: 14970275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.
    Chen YE; Kao SS; Chung RH
    PLoS One; 2016; 11(8):e0160599. PubMed ID: 27482709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing.
    Palmirotta R; Matera S; Curia MC; Aceto G; el Zhobi B; Verginelli F; Guadagni F; Casale V; Stigliano V; Messerini L; Mariani-Costantini R; Battista P; Cama A
    Fam Cancer; 2004; 3(2):117-21. PubMed ID: 15340262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
    Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
    BMC Cancer; 2015 Apr; 15():313. PubMed ID: 25910169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability analysis in hereditary non-polyposis colon cancer using the Bethesda consensus panel of microsatellite markers in the absence of proband normal tissue.
    Chialina SG; Fornes C; Landi C; de la Vega Elena CD; Nicolorich MV; Dourisboure RJ; Solano A; Solis EA
    BMC Med Genet; 2006 Jan; 7():5. PubMed ID: 16426447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.